MorphoSys AG Statistics
Total Valuation
Astrana Health has a market cap or net worth of $1.09 billion. The enterprise value is $1.28 billion.
| Market Cap | 1.09B |
| Enterprise Value | 1.28B |
Important Dates
The next confirmed earnings date is Thursday, August 7, 2025, after market close.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Astrana Health has 49.93 million shares outstanding. The number of shares has increased by 2.40% in one year.
| Current Share Class | 49.93M |
| Shares Outstanding | 49.93M |
| Shares Change (YoY) | +2.40% |
| Shares Change (QoQ) | +5.42% |
| Owned by Insiders (%) | 12.45% |
| Owned by Institutions (%) | 52.61% |
| Float | 37.56M |
Valuation Ratios
The trailing PE ratio is 29.97 and the forward PE ratio is 12.15. Astrana Health's PEG ratio is 0.71.
| PE Ratio | 29.97 |
| Forward PE | 12.15 |
| PS Ratio | 0.47 |
| Forward PS | 0.34 |
| PB Ratio | 1.44 |
| P/TBV Ratio | 5.03 |
| P/FCF Ratio | 20.96 |
| P/OCF Ratio | 17.38 |
| PEG Ratio | 0.71 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.43, with an EV/FCF ratio of 24.62.
| EV / Earnings | 36.65 |
| EV / Sales | 0.57 |
| EV / EBITDA | 11.43 |
| EV / EBIT | 15.53 |
| EV / FCF | 24.62 |
Financial Position
The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.87.
| Current Ratio | 1.70 |
| Quick Ratio | 1.63 |
| Debt / Equity | 0.87 |
| Debt / EBITDA | 3.60 |
| Debt / FCF | 8.66 |
| Interest Coverage | 2.52 |
Financial Efficiency
Return on equity (ROE) is 8.10% and return on invested capital (ROIC) is 5.57%.
| Return on Equity (ROE) | 8.10% |
| Return on Assets (ROA) | 4.04% |
| Return on Invested Capital (ROIC) | 5.57% |
| Return on Capital Employed (ROCE) | 8.52% |
| Revenue Per Employee | $1.18M |
| Profits Per Employee | $18,424 |
| Employee Count | 1,900 |
| Asset Turnover | 1.76 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Astrana Health has paid $27.13 million in taxes.
| Income Tax | 27.13M |
| Effective Tax Rate | 40.84% |
Stock Price Statistics
The stock price has decreased by -55.60% in the last 52 weeks. The beta is 0.86, so Astrana Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | -55.60% |
| 50-Day Moving Average | 24.53 |
| 200-Day Moving Average | 33.88 |
| Relative Strength Index (RSI) | 38.34 |
| Average Volume (20 Days) | 341,329 |
Short Selling Information
The latest short interest is 1.53 million, so 3.07% of the outstanding shares have been sold short.
| Short Interest | 1.53M |
| Short Previous Month | 1.43M |
| Short % of Shares Out | 3.07% |
| Short % of Float | 4.08% |
| Short Ratio (days to cover) | 5.25 |
Income Statement
In the last 12 months, Astrana Health had revenue of $2.25 billion and earned $35.01 million in profits. Earnings per share was $0.73.
| Revenue | 2.25B |
| Gross Profit | 268.76M |
| Operating Income | 82.61M |
| Pretax Income | 96.65M |
| Net Income | 35.01M |
| EBITDA | 112.29M |
| EBIT | 82.61M |
| Earnings Per Share (EPS) | $0.73 |
Balance Sheet
The company has $260.91 million in cash and $451.37 million in debt, giving a net cash position of -$190.46 million or -$3.81 per share.
| Cash & Cash Equivalents | 260.91M |
| Total Debt | 451.37M |
| Net Cash | -190.46M |
| Net Cash Per Share | -$3.81 |
| Equity (Book Value) | 517.71M |
| Book Value Per Share | 15.20 |
| Working Capital | 252.00M |
Cash Flow
In the last 12 months, operating cash flow was $62.85 million and capital expenditures -$10.73 million, giving a free cash flow of $52.12 million.
| Operating Cash Flow | 62.85M |
| Capital Expenditures | -10.73M |
| Free Cash Flow | 52.12M |
| FCF Per Share | $1.04 |
Margins
Gross margin is 11.94%, with operating and profit margins of 3.67% and 1.56%.
| Gross Margin | 11.94% |
| Operating Margin | 3.67% |
| Pretax Margin | 2.95% |
| Profit Margin | 1.56% |
| EBITDA Margin | 4.99% |
| EBIT Margin | 3.67% |
| FCF Margin | 2.32% |
Dividends & Yields
Astrana Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.40% |
| Shareholder Yield | -2.40% |
| Earnings Yield | 3.20% |
| FCF Yield | 4.77% |
Analyst Forecast
The average price target for Astrana Health is $53.29, which is 143.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $53.29 |
| Price Target Difference | 143.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 16.52% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Astrana Health has an Altman Z-Score of 3.95 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.95 |
| Piotroski F-Score | 6 |